Development and pan-cancer validation of an epigenetics-based random survival forest model for prognosis prediction and drug response in OS

被引:0
作者
Yin, Chaoyi [1 ]
Chi, Kede [2 ]
Chen, Zhiqing [1 ]
Zhuang, Shabin [1 ]
Ye, Yongsheng [1 ]
Zhang, Binshan [1 ]
Cai, Cailiang [1 ]
机构
[1] Guangzhou Univ Chinese Med, Dongguan Hosp, Dept Orthopaed, Dongguan, Peoples R China
[2] Zhongshan Hosp Tradit Chinese Med, Dept One Spine Surg, Zhongshan, Peoples R China
关键词
osteosarcoma; epigenetic heterogeneity; single-cell RNA sequencing; random survival forest; prognostic model; drug sensitivity; pan-cancer analysis; OSTEOSARCOMA;
D O I
10.3389/fphar.2025.1529525
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background: Osteosarcoma (OS) exhibits significant epigenetic heterogeneity, yet its systematic characterization and clinical implications remain largely unexplored. Methods: We analyzed single-cell transcriptomes of five primary OS samples, identifying cell type-specific epigenetic features and their evolutionary trajectories. An epigenetics-based Random Survival Forest (RSF) model was constructed using 801 curated epigenetic factors and validated in multiple independent cohorts. Results: Our analysis revealed distinct epigenetic states in the OS microenvironment, with particular activity in OS cells and osteoclasts. The RSF model identified key predictive genes including OLFML2B, ACTB, and C1QB, and demonstrated broad applicability across multiple cancer types. Risk stratification analysis revealed distinct therapeutic response patterns, with low-risk groups showing enhanced sensitivity to traditional chemotherapy drugs while high-risk groups responded better to targeted therapies. Conclusion: Our epigenetics-based model demonstrates excellent prognostic accuracy (AUC>0.997 in internal validation, 0.832-0.929 in external cohorts) and provides a practical tool for treatment stratification. These findings establish a clinically applicable framework for personalized therapy selection in OS patients.
引用
收藏
页数:18
相关论文
共 37 条
  • [21] A prediction model based on random survival forest analysis of the overall survival of elderly female papillary thyroid carcinoma patients: a SEER-based study
    Lun, Yuqiang
    Yuan, Hao
    Ma, Pengwei
    Chen, Jiawei
    Lu, Peiheng
    Wang, Weilong
    Liang, Rui
    Zhang, Junjun
    Gao, Wei
    Ding, Xuerui
    Li, Siyu
    Wang, Zi
    Guo, Jianing
    Lu, Lianjun
    ENDOCRINE, 2024, 85 (02) : 598 - 600
  • [22] Random survival forest model in patients with epithelial ovarian cancer: a study based on SEER database and single center data
    Wei, Luwei
    Chen, Guowei
    Liang, Huiying
    Li, Li
    AMERICAN JOURNAL OF CANCER RESEARCH, 2025, 15 (02): : 769 - 780
  • [23] Development and validation of novel interpretable survival prediction models based on drug exposures for severe heart failure during vulnerable period
    Guo, Yu
    Yu, Fang
    Jiang, Fang-Fang
    Yin, Sun-Jun
    Jiang, Meng-Han
    Li, Ya-Jia
    Yang, Hai-Ying
    Chen, Li-Rong
    Cai, Wen-Ke
    He, Gong-Hao
    JOURNAL OF TRANSLATIONAL MEDICINE, 2024, 22 (01)
  • [24] Development and Validation of Prognostic Model in Transitional Bladder Cancer Based on Inflammatory Response-Associated Genes
    Xie, Zhiwen
    Cai, Jinming
    Sun, Wenlan
    Hua, Shan
    Wang, Xingjie
    Li, Anguo
    Jiang, Juntao
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [25] RF-Lung-DR: Integrating Biological and Drug SMILES Features in a Random Forest-Based Drug Response Predictor for Lung Cancer Cell Lines
    Tran, Thi-Oanh
    Kha, Quang-Hien
    Le, Nguyen Quoc Khanh
    TRUSTWORTHY ARTIFICIAL INTELLIGENCE FOR HEALTHCARE, TAI4H 2024, 2024, 14812 : 157 - 167
  • [26] Development and validation of a model based on immunogenic cell death related genes to predict the prognosis and immune response to bladder urothelial carcinoma
    Chen, Lizhu
    Lin, Jiexiang
    Wen, Yaoming
    Chen, Yu
    Chen, Chuan-ben
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [27] A novel predictive model based on inflammatory response-related genes for predicting endometrial cancer prognosis and its experimental validation
    Wang, Yuting
    Wang, Bo
    Ma, Xiaoxin
    AGING-US, 2023, 15 (11): : 4844 - 4860
  • [28] Development of a risk model based on autophagy-related genes to predict survival and immunotherapy response in ovarian cancer
    Yuwei Chen
    Zhibo Deng
    Yang Sun
    Hereditas, 160
  • [29] Development of a risk model based on autophagy-related genes to predict survival and immunotherapy response in ovarian cancer
    Chen, Yuwei
    Deng, Zhibo
    Sun, Yang
    HEREDITAS, 2023, 160 (01)
  • [30] Development and application of a predictive model for survival and drug therapy based on COVID-19-related lncRNAs in non-small cell lung cancer
    Huang, Ziyuan
    Han, Zenglei
    Zheng, Kairong
    Zhang, Yidan
    Liang, Yanjun
    Zhu, Xiao
    Zhou, Jiajun
    MEDICINE, 2024, 103 (49) : e40629